Category: axes slew of drugs

GlaxoSmithKline’s new boss streamlines R&D, axes slew of drugs

  1. GlaxoSmithKline’s new boss streamlines R&D, axes slew of drugs  Reuters
  2. GlaxoSmithKline’s (GSK) CEO Emma Walmsley on Q2 2017 Results – Earnings Call Transcript  Seeking Alpha
  3. New GlaxoSmithKline chief Walmsley makes early mark with sweeping pharma overhaul  FiercePharma
  4. Glaxo Looks Beyond the Lab  Bloomberg
  5. Full coverage

from Business – Google News http://in.reuters.com/article/us-gsk-results-idINKBN1AB1BH

Advertisements